The global clinical trial supplies market is projected to grow from $5.7 billion in 2025 to $10.7 billion by 2033, at an 8.4% CAGR. This growth is driven by increased R&D investments, rising chronic diseases, and the expansion of biologics, personalized medicine, and decentralized trials requiring advanced cold-chain logistics and just-in-time delivery. Pharmaceutical companies are increasingly outsourcing to specialized logistics and contract organizations to meet regulatory and operational demands. The market's expansion is also supported by globalization of trials into emerging regions with diverse patient populations and cost advantages.
The clinical trial supplies market forecasts growth from $5.7 billion in 2025 to $10.7 billion by 2033. For readers following the health sector, here is Pluang's market snapshot as of Oct 19, 2026 15:51 WIB: out of 150 priced US health stocks, 69 rose and 42 fell. Notable movers include AMRX at USD 19.55 (+1.93%), ELAN at USD 23.97 (+1.78%), and SNY at USD 39.90 (-1.75%).
Starlink Mobile, launched by VEON Ltd. across Ukraine, Kazakhstan, and Bangladesh, has connected over 11 million users in less than a year. The service enables existing 4G phones to access satellite connectivity where terrestrial signals are unavaila...
Medallion Financial Corp. announced it will repurchase $15 million in trust preferred securities from BIMIZCI Fund LLC at 73.66% of face value, costing about $11.05 million plus accrued distributions. This deal includes a five-year standstill agreeme...
Belite Bio, a clinical-stage drug developer focused on retinal diseases, has been approved to move its stock listing from the Nasdaq Capital Market to the Nasdaq Global Select Market, the highest tier on Nasdaq. This uplisting reflects the company's ...
Heineken N.V. has repurchased a total of 8,865,521 shares under the second tranche of its €1.5 billion share buyback program, spending €629.4 million as of October 16, 2026. This includes shares bought on the exchange and from Heineken Holding N.V. T...
ATEN International honored TD SYNNEX with its 2026 Best Sales Performance Award, recognizing exceptional sales results and strong partnership. The award highlights TD SYNNEX's role in expanding market reach and driving growth for ATEN's technology so...
